{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:08:41Z","timestamp":1759226921619,"version":"3.37.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008391","name":"UBS Optimus Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008391","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stanley Thomas Johnson Foundation and the Bangeter-Rhyner Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.05.036","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T15:52:23Z","timestamp":1467388343000},"page":"4263-4269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["PLGA-microencapsulation protects Salmonella typhi outer membrane proteins from acidic degradation and increases their mucosal immunogenicity"],"prefix":"10.1016","volume":"34","author":[{"given":"Juan Manuel","family":"Carre\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Perez-Shibayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gil-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Printz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Pastelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Isibasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Chariatte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantino","family":"Lopez-Macias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Gander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Ludewig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2016.05.036_b0005","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.7189\/jogh.01.010401","article-title":"Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010","volume":"2","author":"Buckle","year":"2012","journal-title":"J Glob Health"},{"issue":"2","key":"10.1016\/j.vaccine.2016.05.036_b0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9973","key":"10.1016\/j.vaccine.2016.05.036_b0015","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2016.05.036_b0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/QCO.0b013e328356ffeb","article-title":"Vaccines for typhoid fever and other salmonelloses","volume":"25","author":"Martin","year":"2012","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.05.036_b0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa051331","article-title":"Spectrum of disease and relation to place of exposure among ill returned travelers","volume":"354","author":"Freedman","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2016.05.036_b0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s100960050361","article-title":"Experience with Salmonella typhi Vi capsular polysaccharide vaccine","volume":"18","author":"Hessel","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.05.036_b0035","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.vaccine.2009.11.051","article-title":"Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever","volume":"28","author":"Froeschle","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.036_b0040","first-page":"164","article-title":"Emergence of Salmonella typhi Vi antigen-negative strains in an epidemic of multidrug-resistant typhoid fever cases in Calcutta, India","volume":"13","author":"Saha","year":"2000","journal-title":"Natl Med J India"},{"issue":"5","key":"10.1016\/j.vaccine.2016.05.036_b0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.05.036_b0050","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI33998","article-title":"The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children","volume":"118","author":"MacLennan","year":"2008","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2016.05.036_b0055","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/IAI.68.6.3344-3348.2000","article-title":"Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium","volume":"68","author":"McSorley","year":"2000","journal-title":"Infect Immun"},{"issue":"1 Pt A","key":"10.1016\/j.vaccine.2016.05.036_b0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.imlet.2014.07.003","article-title":"Plasticity and complexity of B cell responses against persisting pathogens","volume":"162","author":"Perez-Shibayama","year":"2014","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2016.05.036_b0065","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","article-title":"Molecular basis of bacterial outer membrane permeability revisited","volume":"67","author":"Nikaido","year":"2003","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2016.05.036_b0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/eji.200838185","article-title":"TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens","volume":"39","author":"Cervantes-Barragan","year":"2009","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.05.036_b0075","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.4049\/jimmunol.1302526","article-title":"IFN-gamma-producing CD4+ T cells promote generation of protective germinal center-derived IgM+ B cell memory against Salmonella Typhi","volume":"192","author":"Perez-Shibayama","year":"2014","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2016.05.036_b0080","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.27.7.1640-1645.1989","article-title":"Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever","volume":"27","author":"Ortiz","year":"1989","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.05.036_b0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2567.2005.02263.x","article-title":"Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response","volume":"117","author":"Secundino","year":"2006","journal-title":"Immunology"},{"issue":"5977","key":"10.1016\/j.vaccine.2016.05.036_b0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1126\/science.1180346","article-title":"Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults","volume":"328","author":"MacLennan","year":"2010","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2016.05.036_b0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.imlet.2004.01.010","article-title":"Induction of cellular immune response and anti-Salmonella enterica serovar typhi bactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever","volume":"93","author":"Salazar-Gonzalez","year":"2004","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.036_b0100","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2016.05.036_b0105","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.nano.2010.02.002","article-title":"In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems","volume":"6","author":"Semete","year":"2010","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.05.036_b0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"Lu","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"issue":"17","key":"10.1016\/j.vaccine.2016.05.036_b0115","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2217\/nnm.14.156","article-title":"Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery","volume":"9","author":"Pavot","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.vaccine.2016.05.036_b0120","first-page":"0","article-title":"Peptide\/protein vaccine delivery system based on PLGA particles","volume":"October 29","author":"Allahyari","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.05.036_b0125","first-page":"1","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"11","author":"Silva","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2016.05.036_b0130","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0264-410X(02)00521-2","article-title":"Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro","volume":"21","author":"Audran","year":"2003","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.05.036_b0135","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.vaccine.2005.10.032","article-title":"Encapsulation of proteins and peptides into biodegradable poly(D, L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells","volume":"24","author":"Waeckerle-Men","year":"2006","journal-title":"Vaccine"},{"issue":"235\u201370","key":"10.1016\/j.vaccine.2016.05.036_b0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.immunol.15.1.235","article-title":"Neutralizing antiviral B cell responses","volume":"15","author":"Bachmann","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.05.036_b0145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.drudis.2011.04.006","article-title":"Particulate vaccines: on the quest for optimal delivery and immune response","volume":"16","author":"De Temmerman","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2016.05.036_b0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2014.04.014","article-title":"Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery","volume":"60","author":"Joshi","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.036_b0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.addr.2004.09.009","article-title":"Exploiting receptor biology for oral vaccination with biodegradable particulates","volume":"57","author":"Foster","year":"2005","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16303395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16303395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T06:03:57Z","timestamp":1600841037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16303395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":31,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X16303395"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLGA-microencapsulation protects Salmonella typhi outer membrane proteins from acidic degradation and increases their mucosal immunogenicity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}